Clinical phenotypes and imaging evolution of hepatic portal venous gas under conservative management: a single-center case series using albumin and procalcitonin as prognostic stratification anchors - Scorecard - MDSpire
Advertisement
Clinical phenotypes and imaging evolution of hepatic portal venous gas under conservative management: a single-center case series using albumin and procalcitonin as prognostic stratification anchors
Clinical Scorecard: Characterization of Clinical Features and Imaging Changes in Hepatic Portal Venous Gas Managed Conservatively: A Case Series from a Single Center Utilizing Albumin and Procalcitonin for Prognostic Assessment
At a Glance
Category
Detail
Condition
Key Mechanisms
Target Population
Patients diagnosed with HPVG, primarily individuals aged 60 and above.
Care Setting
Key Highlights
in_hospital_mortality_rate
Guideline-Based Recommendations
Diagnosis
Management
S
p
e
c
i
f
y
h
i
g
h
-
r
i
s
k
f
e
a
t
u
r
e
s
s
u
c
h
a
s
p
e
r
i
t
o
n
e
a
l
i
r
r
i
t
a
t
i
o
n
o
r
b
o
w
e
l
i
s
c
h
e
m
i
a
.
Monitoring & Follow-up
Risks
Patient & Prescribing Data
All patients received conservative management without surgical intervention during the study period from January 2017 to June 2025.
